Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-17-000084
Filing Date
2017-11-13
Accepted
2017-11-13 08:02:02
Documents
1
Period of Report
2017-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151057810891449.html 4  
1 FORM 4 wf-form4_151057810891449.xml 4 3838
  Complete submission text file 0001615219-17-000084.txt   5192
Mailing Address 99 HAYDEN AVENUE, SUITE 500 LEXINGTON MA 02421
Business Address
Tung Roger D (Reporting) CIK: 0001594857 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 171193220

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations